Literature DB >> 2151320

Effect of atrial natriuretic factor on platelet function in whole blood ex-vivo in man.

C C Lang1, C S Lau, J J Belch, A D Struthers.   

Abstract

Atrial natriuretic factor (ANF) binding sites have been shown to be present on human platelet membranes. We investigated the effect of an infusion of ANF 5 pmol.kg-1.min-1 on platelet aggregation in whole blood ex-vivo in 8 normal volunteers. Spontaneous platelet aggregation, collagen (0.6-2 micrograms.m.-1)-induced or ADP (0.5-2.0 microM)-induced aggregation was not affected by ANF. Plasma aldosterone was however significantly attenuated by ANF. These results show that a pharmacological dose of ANF does not affect platelet aggregation in man. These results suggest that the high plasma levels of ANF normally achieved in chronic heart failure or acute myocardial infarction are unlikely to contribute to the platelet hyperractivity, often observed in these conditions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2151320     DOI: 10.1007/bf00316102

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  14 in total

1.  A platelet counting technique to study platelet aggregation in whole blood: application to pathologically low platelet counts.

Authors:  A R Saniabadi; G Lowe; J Belch; J C Barbenel; C D Forbes
Journal:  Platelets       Date:  1990       Impact factor: 3.862

2.  Decreased density of binding sites for atrial natriuretic peptide on platelets of patients with severe congestive heart failure.

Authors:  E L Schiffrin
Journal:  Clin Sci (Lond)       Date:  1988-02       Impact factor: 6.124

3.  Platelet aggregation inhibitory effects of the new positive inotropic agents pimobendan and UD CG 212 in whole blood.

Authors:  A R Saniabadi; G D Lowe; J J Belch; C D Forbes
Journal:  Cardiovasc Res       Date:  1989-03       Impact factor: 10.787

Review 4.  Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis.

Authors:  J H Laragh
Journal:  N Engl J Med       Date:  1985-11-21       Impact factor: 91.245

Review 5.  Atrial natriuretic factor receptor heterogeneity and stimulation of particulate guanylate cyclase and cyclic GMP accumulation.

Authors:  D C Leitman; F Murad
Journal:  Endocrinol Metab Clin North Am       Date:  1987-03       Impact factor: 4.741

6.  Atrial natriuretic peptide in acute myocardial infarction.

Authors:  H Tomoda
Journal:  Am J Cardiol       Date:  1988-11-15       Impact factor: 2.778

7.  Potentiation of platelet aggregation by atrial natriuretic peptide.

Authors:  A L Loeb; A R Gear
Journal:  Life Sci       Date:  1988       Impact factor: 5.037

8.  Effect of native and synthetic atrial natriuretic factor on cyclic GMP.

Authors:  P Hamet; J Tremblay; S C Pang; R Garcia; G Thibault; J Gutkowska; M Cantin; J Genest
Journal:  Biochem Biophys Res Commun       Date:  1984-09-17       Impact factor: 3.575

9.  Effects of atrial natriuretic factor on human platelet function.

Authors:  R De Caterina; M Volpe; S A Atlas; B B Weksler
Journal:  Life Sci       Date:  1985-10-14       Impact factor: 5.037

10.  Cyclic GMP as mediator and biological marker of atrial natriuretic factor.

Authors:  P Hamet; J Tremblay; S C Pang; R Skuherska; E L Schiffrin; R Garcia; M Cantin; J Genest; R Palmour; F R Ervin
Journal:  J Hypertens Suppl       Date:  1986-06
View more
  2 in total

1.  Atrial natriuretic peptide increases inflammation, infarct size, and mortality after experimental coronary occlusion.

Authors:  Aiilyan K Houng; Rachel A McNamee; Attila Kerner; Pallavi Sharma; Almois Mohamad; Jonathan Tronolone; Guy L Reed
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-01-02       Impact factor: 4.733

2.  Platelet Function in CKD: A Systematic Review and Meta-Analysis.

Authors:  Constance C F M J Baaten; Marieke Sternkopf; Tobias Henning; Nikolaus Marx; Joachim Jankowski; Heidi Noels
Journal:  J Am Soc Nephrol       Date:  2021-05-03       Impact factor: 14.978

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.